Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

Carrie Underwood probably had a vision of how her version of “America the Beautiful” would be received after accepting Donald ...

Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

诺和诺德 (NVO.US)周五宣布，在一项后期试验中，该公司流行的肥胖治疗药物semaglutide (名为Wegovy)在7.2毫克的较高剂量下于72周内减重20.7%。这家丹麦制药商援引其STEP-UP 3b期研究的数据称，服用常规Wegovy 2.4毫克的患者在此期间体重减轻了17.5%，而服用安慰剂对照组的患者体重减轻了2.4%。

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be ...